338 related articles for article (PubMed ID: 11910511)
21. Association between benign and malignant peripheral nerve sheath tumors in NF1.
Tucker T; Wolkenstein P; Revuz J; Zeller J; Friedman JM
Neurology; 2005 Jul; 65(2):205-11. PubMed ID: 16043787
[TBL] [Abstract][Full Text] [Related]
22. Malignant peripheral nerve sheath tumor with a t(X;18).
Vang R; Biddle DA; Harrison WR; Heck K; Cooley LD
Arch Pathol Lab Med; 2000 Jun; 124(6):864-7. PubMed ID: 10835522
[TBL] [Abstract][Full Text] [Related]
23. Reverse transcription-polymerase chain reaction in situ hybridization for SYT-SSX fusion gene transcripts in synovial sarcomas.
Kawauchi S; Fukuda T; Chochi Y; Kondo T; Oga A; Sasaki K
Int J Mol Med; 2005 Oct; 16(4):763-6. PubMed ID: 16142418
[TBL] [Abstract][Full Text] [Related]
24. Primary renal synovial sarcoma: molecular and morphologic delineation of an entity previously included among embryonal sarcomas of the kidney.
Argani P; Faria PA; Epstein JI; Reuter VE; Perlman EJ; Beckwith JB; Ladanyi M
Am J Surg Pathol; 2000 Aug; 24(8):1087-96. PubMed ID: 10935649
[TBL] [Abstract][Full Text] [Related]
25. Detection of SYT-SSX fusion transcripts in paraffin-embedded tissues of synovial sarcoma by reverse transcription-polymerase chain reaction.
Wei Y; Wang J; Zhu X; Shi D; Hisaoka M; Hashimoto H
Chin Med J (Engl); 2002 Jul; 115(7):1043-7. PubMed ID: 12150740
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
27. [Demonstration of SYT-SSX11/2 fusion transcripts in synovial sarcomas using RT-PCR].
Willeke F; Mechtersheimer G; Schwarzbach M; Weitz J; Lehnert T; Herfarth C; Otto HF; von Knebel Doeberitz M; Ridder R
Verh Dtsch Ges Pathol; 1998; 82():215-9. PubMed ID: 10095437
[TBL] [Abstract][Full Text] [Related]
28. Confirmation of mutation landscape of NF1-associated malignant peripheral nerve sheath tumors.
Sohier P; Luscan A; Lloyd A; Ashelford K; Laurendeau I; Briand-Suleau A; Vidaud D; Ortonne N; Pasmant E; Upadhyaya M
Genes Chromosomes Cancer; 2017 May; 56(5):421-426. PubMed ID: 28124441
[TBL] [Abstract][Full Text] [Related]
29. Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Hirbe AC; Kaushal M; Sharma MK; Dahiya S; Pekmezci M; Perry A; Gutmann DH
Cancer; 2017 Apr; 123(7):1194-1201. PubMed ID: 27875628
[TBL] [Abstract][Full Text] [Related]
30. Detection of a variant SYT-SSX1 fusion in a case of predominantly epithelioid synovial sarcoma.
Sanders ME; van de Rijn M; Barr FG
Mol Diagn; 1999 Mar; 4(1):65-70. PubMed ID: 10229776
[TBL] [Abstract][Full Text] [Related]
31. Differential NF1, p16, and EGFR patterns by interphase cytogenetics (FISH) in malignant peripheral nerve sheath tumor (MPNST) and morphologically similar spindle cell neoplasms.
Perry A; Kunz SN; Fuller CE; Banerjee R; Marley EF; Liapis H; Watson MA; Gutmann DH
J Neuropathol Exp Neurol; 2002 Aug; 61(8):702-9. PubMed ID: 12152785
[TBL] [Abstract][Full Text] [Related]
32. Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors. I. The role of tumor suppressor mutations.
Carroll SL; Stonecypher MS
J Neuropathol Exp Neurol; 2004 Nov; 63(11):1115-23. PubMed ID: 15581179
[TBL] [Abstract][Full Text] [Related]
33. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
[TBL] [Abstract][Full Text] [Related]
34. High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization.
Mantripragada KK; Spurlock G; Kluwe L; Chuzhanova N; Ferner RE; Frayling IM; Dumanski JP; Guha A; Mautner V; Upadhyaya M
Clin Cancer Res; 2008 Feb; 14(4):1015-24. PubMed ID: 18281533
[TBL] [Abstract][Full Text] [Related]
35. Subclassification of nerve sheath tumors by gene expression profiling.
Holtkamp N; Reuss DE; Atallah I; Kuban RJ; Hartmann C; Mautner VF; Frahm S; Friedrich RE; Algermissen B; Pham VA; Prietz S; Rosenbaum T; Estevez-Schwarz L; von Deimling A
Brain Pathol; 2004 Jul; 14(3):258-64. PubMed ID: 15446580
[TBL] [Abstract][Full Text] [Related]
36. Microarray-based copy number analysis of neurofibromatosis type-1 (NF1)-associated malignant peripheral nerve sheath tumors reveals a role for Rho-GTPase pathway genes in NF1 tumorigenesis.
Upadhyaya M; Spurlock G; Thomas L; Thomas NS; Richards M; Mautner VF; Cooper DN; Guha A; Yan J
Hum Mutat; 2012 Apr; 33(4):763-76. PubMed ID: 22331697
[TBL] [Abstract][Full Text] [Related]
37. Lack of SYT-SSX fusion transcripts in malignant peripheral nerve sheath tumors on RT-PCR analysis of 34 archival cases, by Tamborini E., et al.
O'Sullivan MJ; Pfeifer JD; Dehner LP
Lab Invest; 2003 Mar; 83(3):301-2; author reply 302-3. PubMed ID: 12649331
[No Abstract] [Full Text] [Related]
38. Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors.
Holtkamp N; Mautner VF; Friedrich RE; Harder A; Hartmann C; Theallier-Janko A; Hoffmann KT; von Deimling A
Acta Neuropathol; 2004 Feb; 107(2):159-68. PubMed ID: 14673600
[TBL] [Abstract][Full Text] [Related]
39. New Frontiers in Therapy of Peripheral Nerve Sheath Tumors in Patients With Neurofibromatosis Type 1: Latest Evidence and Clinical Implications.
Marjanska A; Galazka P; Wysocki M; Styczynski J
Anticancer Res; 2020 Apr; 40(4):1817-1831. PubMed ID: 32234870
[TBL] [Abstract][Full Text] [Related]
40. SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: a gain of function of the t(X;18)(p11.2;q11.2) translocation.
Xie Y; Skytting B; Nilsson G; Gasbarri A; Haslam K; Bartolazzi A; Brodin B; Mandahl N; Larsson O
Cancer Res; 2002 Jul; 62(13):3861-7. PubMed ID: 12097301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
